SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-21-064986
Filing Date
2021-12-13
Accepted
2021-12-13 16:21:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea152190-13da1feld_180life.htm SC 13D/A 51332
  Complete submission text file 0001213900-21-064986.txt   52642
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90013 | Film No.: 211488344
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 DURHAM TERRACE LONDON X0 W25PB
Business Address
Feldmann Marc (Filed by) CIK: 0001832327 (see all company filings)

Type: SC 13D/A